product portfolio
What we do
APIs and Intermediates:
We are a specialized pharma company focusing on niche therapeutic areas of CNS, ARVs and controlled substances. Our specialization in unique CNS segments like ADHD, Anti-psychotics, Anti-vertigo, Anti-inflammatory, Pain management, Alzheimer disease and others gives ZCL the leverage to outclass the competition. We are moving up the value chain adding capacity for more APIs.

CMO:
With the best in class manufacturing facilities with accreditation and state-of-the-art research platform besides brilliant minds in our R&D we have embarked on establishing contract manufacturing organization. We have many on-going contract manufacturing projects that involve complex chemistry and technological excellence.

Active Pharma Ingredients (APIs)
Product Status Pharmacoepeia CAS No. Therapeutic Use Enquiry
Apixaban DMF* In-house 503612-47-3 Anticoagulant Enquire Now
Alprazolam Tech pack USP/EP 28981-97-7 Anxiolytic Enquire Now
Aripiprazole USDMF, CEP, KDMF USP/EP 129722-12-9 Anti-depressant/Anti-psychotic Enquire Now
Atomoxetine HCl CEP, USDMF, TDMF, IDL, CA-DMF USP/EP 82248-59-7 Attention Deficit Hyperactivity Disorder (ADHD) Enquire Now
Betahistine Dihydrochloride CEP, TDMF, CA-DMF, ANVISA, Jordan, Thailand DMF USP/BP/EP/IP 5579-84-0 Anti-Vergo Enquire Now
Clozapine USDMF, CEP*, CA-DMF USP/EP/IP 5786-21-0 Anti-psychotic Enquire Now
Dapagliflozin propanediol monohydrate USDMF In-house 960404-48-2 Anti-diabetic Enquire Now
Dapsone DMF* USP/EP/IP 80-08-0 Anti fungal, Anti acne, Anti-leprosy Enquire Now
Dexmethylphenidate HCl Tech pack In-house 19262-68-1 Attention Deficit Hyperactivity Disorder (ADHD) Enquire Now
Empagliflozin Tech pack In-house 864070-44-0 Anti-diabetic Enquire Now
Eslicarbazepine Acetate USDMF In-house/IP 236395-14-5 Anti-epileptic Enquire Now
Felbinac EDMF BP/EP/JP 5728-52-9 Anti-inflammatory Enquire Now
Fluvoxamine Maleate USDMF, CEP, TDMF USP/BP/EP/IP 61718-82-9 Anti-depressant Enquire Now
Levomepromazine Maleate CEP*, EDMF EP 7104-38-3 Anti-psychotic Enquire Now
Lurasidone HCl USDMF In-house 367514-88-3 Anti-psychotic Enquire Now
Memanne HCl USDMF, AUSDMF, KDMF, EDMF USP/IP 41100-52-1 Alzheimer Disease Enquire Now
Methylphenidate HCl CEP USP/EP 298-59-9 Attention Deficit Hyperactivity Disorder (ADHD) Enquire Now
Mirabegron Tech pack In-house 223673-61-8 Treatment of overactive bladder Enquire Now
Modafinil Tech pack USP/EP 68693-11-8 CNS Stimulant Enquire Now
Olanzapine Tech pack USP 132539-06-1 Anti-psychotic Enquire Now
Pirfenidone USDMF & CEP In-house 53179-13-8 Anti-tablerow3 / Anti-Rheumatic Enquire Now
Queapine Fumarate USDMF, AUSDMF, CEP & KDMF, CADMF USP/EP 111974-72-2 Anti-psychotic Enquire Now
Rivaroxaban USDMF, EDMF, CA-DMF, TDMF In-house 366789-02-8 Anti-coagulant Enquire Now
Ticagrelor Tech pack In-house 274693-27-5 Platelet aggregaon inhibitor Enquire Now
Zonisamide USDMF, JDMF*, Indonesia DMF USP, JP 68291-97-4 Anti-convulsant Enquire Now
Product under development / evaluation
Cannabidio Under Development In-house 13956-29-1 Anti-Epileptics Enquire Now
Darunavir (Amorphous) Under Development In-house 206361-99-1 Anretroviral Enquire Now
Laninamivir Under Development In-house 203120-46-1 Influenza antiviral Enquire Now
Maraviroc Under Development In-house 376348-65-1 Anretroviral Enquire Now
Memanne base Under Development In-house 19982-08-02 Alzheimer Disease Enquire Now
Dabigatran Etexilate mesylate Under Evalution In-house 872728-81-9 Anti-Coagulant Enquire Now
Darunavir Ethanolate Under Evalution In-house 635728-49-3 Treatment of AIDS and HIV infections Enquire Now
Hydroxyzine HCl Under Evalution In-house 2192-20-3 Antihistamine Enquire Now
Irbesartan Under Evalution In-house 138402-11-6 Antihypertensive Enquire Now
Ivabradine HCl Under Evalution In-house 148849-67-6 Cardiovascular Enquire Now
Miglustat Under Evalution In-house 72599-27-0 Gaucher Disease Enquire Now
Olmesartan Under Evalution In-house 144689-63-4 Anhypertensive Enquire Now
Solifenacin Succinate Under Evalution In-house 242478-38-2 Urologicals Enquire Now
Telmisartan Under Evalution In-house 144701-48-4 Anhypertensive Enquire Now
Betahistine Mesylate Tech pack EP/JP/IP 54856-23-4 Vertigo Enquire Now
Cilostazol Tech pack USP 73963-72-1 Anti-thrombotic, Anti-platelet agent Enquire Now
Guanfacine HCl Tech pack USP 29110-48-3 Attention Deficit Hyperactivity Disorder (ADHD), Hypertension Enquire Now
Loxoprofen sodium Tech pack JP 80382-23-6 Anti-inflammatory, Analgesic Enquire Now
Memantine HCl USDMF USP 41100-52-1 Alzheimer Disease Enquire Now
Oxazepam Tech pack EP 604-75-1 Anxiolytic Enquire Now
Quetiapine Fumarate USDMF* & CEP* USP/EP 111974-72-2 Anti-psychotic Enquire Now
Trifluoperazine HCl Tech pack USP/BP/EP/IP 440-17-5 Anti-psychotic Enquire Now
Zaltoprofen KDMF JP 74711-43-6 Anti-inflammatory Enquire Now
Zonisamide Tech pack USP/EP 68291-97-4 Anti-convulsant Enquire Now
 
Brexpiprazole Under development in-house 913611-97-9 Antipsychotic Enquire Now
Bromazepam Under Scale up EP 1812-30-2 Anxiolytic Enquire Now
Eluxadoline Under development In-house 864821-90-9 Irritable bowel syndrome Enquire Now
*Under filing
Disclaimer: All transacons are carried out in conformity with the patent laws applicable in the user country.
                     Responsibility with respect to third pare’s patent rights in a specific country lies exclusively with the buyer.
                     The therapeuc use shown against each product is indicave only and is not for adversing ZCL products.
                     Patented Products are available for R&D use as per permied under 35 USC ¶ 271 (e) (1)

Advanced Intermediates
Product CAS No. End Use Structure Enquiry
Ethyl 6-(4-iodophenyl)-1-(4-methoxy phenyl)-7- oxo-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4- c]pyridine-3-carboxylate 473927-64-9 Apixaban Enquire Now
Ethyl 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro1H-pyrazolo[3,4-c]pyridine-3-carboxylate; 503614-91-3 Apixaban Enquire Now
3, 3-dichloro-1-(4-iodophenyl) piperidin-2-one 545445-10-1 Apixaban Enquire Now
1-(2,3-Dichlorophenyl) Piperazine HCl 119532-26-2 Aripiprazole Enquire Now
N-Benzhydrylpiperazine 841-77-0 Cinnarizine Enquire Now
5-Bromo-2-chloro4'ethoxydiphenylmethane 461432-23-5 Dapagliflozin propanediol Enquire Now
1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-,2,3,4,6-tetraacetate, (1S)- D-Glucitol 461432-25-7 Dapagliflozin propanediol Enquire Now
2,3,4,6-tetra-O-trimethylsilyl-ß-D-glucolactone 32384-65-9 Dapagliflozin, Empagliflozin Enquire Now
4,4'-sulfonylbis(nitrobenzene) 1156-50-9 Dapsone Enquire Now
Bis(4-nitrophenyl)sulfane 1223-31-0 Dapsone Enquire Now
Benzenesulfonamide, 4-amino-N-[(2R,3S)-3-amino-2- hydroxy-4-phenylbutyl]-N-(2-methylpropyl) 169280-56-2 Darunavir Enquire Now
Carbamic acid, N-[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1- (phenylmethyl)propyl]-,1,1-dimethylethylester 191226-98-9 Darunavir, Fosamprenavir Enquire Now
(10S)-10,11-Dihydro-10-hydroxy-5Hdibenz[b,f]azepine-5-carboxamide 104746-04-5 Eslicarbazepine acetate Enquire Now
10,11-Dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide 29331-92-8 Eslicarbazepine acetate Enquire Now
4,4'-Difluorobenzhydrylpiperazine 27469-60-9 Flunarizine Enquire Now
(1E)-N-Hydroxy-5-Methoxy-1-(4-Trifluoromethylphenyl)Pentan-1-Imine 61747-22-6 Fluvoxamine Enquire Now
2-Bromo-4'-benzyloxy-3'-nitroacetophenone 43229-01-2 Formoterol Enquire Now
2,4-Dihydro-4-[4-[4-(4-methoxyphenyl)-1- piperazinyl]phenyl]-2-(1-methyl propyl)-3H-1,2,4-triazol-3-one 252964-68-4 Itraconazole Enquire Now
1-Acetyl-4-(4-hydroxyphenyl) piperazine 67914-60-7 Ketoconazole Enquire Now
(1R)-2-{[2-(4-nitrophenyl)ethyl]amino}-1-phenylethanol 391901-45-4 Mirabegron Enquire Now
(1R)-2-{[2-(4-nitrophenyl)ethyl]amino}-1-phenylethanol 223673-34-5 Mirabegron Enquire Now
5-methylpyridin-2(1H)-one/2-Hydroxy-5- methylpyridine 1003- 68-5 Mirabegron Enquire Now
Dibenzo [b, f] [1, 4] thiazepin- 11(10H)-one 3159-07-7 Quetiapine fumarate Enquire Now
1-Aminoindan 34698-41-4 Rasagiline Enquire Now
4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one hydrochloride 898543-06-1 Rivaroxaban Enquire Now
2-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione 446292-08-6 Rivaroxaban Enquire Now
2-(((3aR,4S,6R,6aS)-6-((5-amino-6-chlo ro-2-(propylthio)pyrimidin-4-yl)amino) -2,2-dimethyltetrahydro-3aH-cyclo penta[d][1,3]dioxol-4-yl)oxy)ethanol 376608-74-1 Ticagrelor Enquire Now
1-Acetamido 3,5-dimethyl Adamantane* 19982-07-1 Memantine Enquire Now
N-[1-(benzyl)-4-(methoxymethyl)-4-piperidinyl]-N-phenyl Propanamide oxalate 61086-13-3 Alfentanil & Sufentanil Enquire Now
(1H)-7-(4’-bromobutoxy)-3,4-dihydro-2-quinolinone 1297225-34-5 Aripiprazole Enquire Now
3-(methylamino)-1-phenylpropan-1-ol 42142-52-9 Atomoxetine Fluoxetine Nisoxetine Enquire Now
N-(1,4-Benzodioxan-2-carbonyl)-piperazine 70918-00-2 Doxazosin Enquire Now
4-Hydroxy-3, 5-dimethyl benzonitrile 4198-90-7 Etravirine Enquire Now
(S)-1-chloro-3-[(4-chloro-E-benzylidene)-amino]-propan-2-ol 1345879-87-9 Linezolid Enquire Now
2-{4-[(2-oxocyclopentyl)methyl]phenyl}propanoic acid 68767-14-6 Loxoprofen Sodium Enquire Now
1R)-2-{[2-(4-aminophenyl)ethyl]amino}-1-phenylethanol hydrochloride 521284-22-0 Mirabegron Enquire Now
2-Methyl-10H-thieno[2,3-b][1,5] benzo diazepine-4-amine HCl 138564-60-0 Olanzapine Enquire Now
5-methyl-2-(2-nitrophenylamino) thiophene-3-carbonitrile 138564-59-7 Olanzapine Enquire Now
N-Isopropyl-4-(4-hydroxyphenyl)-piperazine 67914-97-0 Terconazole Enquire Now
2-(Trifluoromethyl)-phenothiazine 92-30-8 Trifluoperazine Enquire Now
Disclaimer: All transacons are carried out in conformity with the patent laws applicable in the user country.
                     Responsibility with respect to third pare’s patent rights in a specific country lies exclusively with the buyer.
                     The therapeuc use shown against each product is indicave only and is not for adversing ZCL products.
                     Patented Products are available for R&D use as per permied under 35 USC ¶ 271 (e) (1)
Intermediate for controlled substances
Product CAS No. End Use Structure Enquiry
N-[1-(benzyl)-4-(methoxymethyl)-4-piperidinyl]-N-phenyl Propanamide oxalate 61086-13-3 Alfentanil & Sufentanil Enquire Now
N-[4-(methoxymethyl)-piperidine-4-yl]-N-phenylpropanamide monohydrochloride & Base 84196-16-7 & 61086-18-8 Alfentanil & Sufentanil Enquire Now
N-(1-Benzylpiperidin-4-yl)-N-phenylpropanamide Hydrochloride 5156-58-1 Fentanil Enquire Now
Methyl 4-(phenyl-propionyl-amino)-piperidine-4-carboxylate HCl 61085-87-8 Remifentanil Enquire Now
N-[4-(methoxymethyl)-piperidine-4-yl)]-N-phenylpropanamide HCl 84196-16-7 Sufentani Enquire Now
1-(2-bromoethyl)-4-ethyl-1,4-dihydro-5Htetrazol-5- one 84501-67-7 Alfentanil Enquire Now
N-[(4-methoxymethyl-1-benzyl)-4-piperidinyl]-N-phenyl propanamide monohydrochloride 84255-05-0 Alfentanil & Sufentanil Enquire Now
Chloromethyl cyclopropane 5911-08-0 Buprenorphine Enquire Now
Bromomethyl cyclopropane 7051-34-5 Buprenorphine Enquire Now
N-[(4-Methoxymethyl)-4-piperidinyl]-N-phenylpropanamide 61086-18-8 Sufentanil Enquire Now
*USDMF available
Disclaimer: All transacons are carried out in conformity with the patent laws applicable in the user country.
                     Responsibility with respect to third pare’s patent rights in a specific country lies exclusively with the buyer.
                     The therapeuc use shown against each product is indicave only and is not for adversing ZCL products.
                     Patented Products are available for R&D use as per permied under 35 USC ¶ 271 (e) (1)
Methyl Phenidate Series
Product CAS No. Structure Enquiry
Phenyl-(2-pyridyl acetamide) 7251-52-7 Enquire Now
Phenyl-2-(2'-piperidyl)acetamide 19395-39-2 Enquire Now
Threo phenyl-2-piperidyl acetamide* 50288-62-5 Enquire Now
dl-threo ritalinic acid* 54631-24-2 Enquire Now
d-threo ritalinic acid hydrohloride* 82993-81-5 Enquire Now
dl-threo-Ritalinic acid HCl 1382859-13-3 Enquire Now
d-threo-Ritalinic acid HCl* 741705-70-4 Enquire Now
Under Scale-up / New Development
Product CAS No. End Use Status Structure Enquiry
4-Amino-2-fluoro-N-methylbenzamide 915087-25-1 Apalutamide, Enzalutamide Underscale-up Enquire Now
(3S)-3-[4-[(5-Bromo-2-chlorophenyl) methyl]phenoxy]tetrahydrofuran 915095-89-5 Empagliflozin Under development Enquire Now
(S)-(5-bromo-2-chlorophenyl)(4-((tetrahydrofuran-3-yl) oxy) phenyl)methanone 915095-84-0 Empagliflozin Under development Enquire Now
(5-bromo-2-chlorophenyl)(4-fluorophenylmethanone 915095-85-1 Empagliflozin Under development Enquire Now
(2R,3R,4R,5S,6S)-2- (acetoxymethyl)-6-(4-chloro- 3-(4-(((S)-tetrahydrofuran-3- yl)oxy)benzyl)phenyl)tetrahy dro-2Hpyran-3,4,5-triyl triacetate 915095-99-7 Empagliflozin Under development Enquire Now
N-Methyl-2-fluoro-4-(1,1-dimethyl cyanomethyl) aminobenzamide 915095-85-1 Enzalutamide Under development Enquire Now
α-D-Glucopyranoside, methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, 2,3,4,6-tetraacetate 714269-58-6 Dapagliflozin propanediol Under development Enquire Now
2-Chloro-1-Dimethylaminopropane HC 4584-49-0 Methadone Under development Enquire Now
2-(2-[3-(3-[2-(7-chloroquinolin-2-yl)ethenyl) phenyl)-3-hydroxy-npropyl]phenyl)-2-propan-1-ol 142569-70-8 Montelukast Underscale-up Enquire Now
1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one 6969-71-7 Trazodone Underscale-up Enquire Now
Disclaimer: Users are responsible for all patent related issue for our offered products.
                     The therapeutic use shown against each product is indicative only and is not for advertising ZCL products.
                     Patented Products are available for R&D use as per permitted under 35 USC ¶ 271 (e) (1)

Disclaimer
Information given herein is offered in good faith as accurate, but without guarantee. Conditions of use and suitability of the product for particular uses are beyond our control. All risks of use of the product are therefore assumed by the user. ZCL Chemicals Limited EXPRESSLY DISCLAIMS ALL WARRANTIES OF EVERY KIND AND NATURE, INCLUDING WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE IN RESPECT TO THE USE OR SUITABILITY OF THE PRODUCT. Appropriate warnings and safe handling procedures should be provided to handlers and users.

Alteration of this document is strictly prohibited.

No statement contained herein concerning a possible or suggested use of any material, product or design is intended, or should be construed, to grant any license under any patent or other intellectual property right of ZCL Chemicals Limited or any of its associates or its affiliates covering such use or design, or as a recommendation for the use of such material, product or design in the infringement of any patent or other intellectual property right. The products are sold subject to ZCL Chemicals Limited Standard Conditions of Sale, which are available upon request.
Socialize with us